Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome

Summary

This is a Group Sequential Test multicenter, randomized, double blind, placebo controlled phase II proof of concept trial with parallel groups to evaluate the efficacy and the safety of BP1.4979 15mg BID compared to placebo in RLS patients during 2 weeks double blind treatment.

Timeline

Start

2018-02-06

Primary completion

2020-04-29

Completion

2020-04-29

Outcome

Outcome not reported

Stopped (Enrollment): “Study facing recruitment difficulties related to stringent eligibility criteria”

Drugs

Indications